间质性肺疾病与肺癌切除术后结局的关联
基于美国胸外科医师学会普胸外科数据库的回顾性队列分析,纳入2009至2019年因非小细胞肺癌行肺切除术的患者,比较有无间质性肺疾病(ILD)者的基线与术后结局。ILD发生率为1.5%(1873/128,723),ILD患者术后死亡率5.1%对1.2%、急性呼吸窘迫综合征1.9%对0.5%、复合并发症与死亡率13.2%对7.4%,均显著升高(P<.001)。多因素校正后ILD仍是死亡的强预测因素(OR 3.94,95%CI 3.09-5.01,P<.001)。
要点
- 因非小细胞肺癌行肺切除术的患者中,ILD发生率为1.5%(1873/128,723)。
- ILD患者术后死亡率5.1%对1.2%、ARDS 1.9%对0.5%、复合并发症与死亡率13.2%对7.4%,均显著升高(P<.001)。
- 校正合并症、肺功能、切除范围和中心容量后,ILD仍为死亡的强预测因素(OR 3.94,95%CI 3.09-5.01,P<.001)。
核心结论
- ILD是肺癌切除术后手术死亡和并发症的危险因素,即使肺功能正常者亦如此。
研究设计与样本
- 回顾性队列分析,使用美国胸外科医师学会普胸外科数据库,纳入2009至2019年因非小细胞肺癌行肺切除术的患者。
- 按有无ILD(基于临床、影像或病理证据定义的间质纤维化)比较基线与术后结局,并以多因素logistic回归识别术后死亡、急性呼吸窘迫综合征及复合并发症与死亡的危险因素。
主要发现
- ILD记录于1.5%(1873/128,723)因非小细胞肺癌行肺切除术的患者。
- ILD患者较无ILD者更可能吸烟(90% vs 85%,P<.001)、有肺动脉高压(6% vs 1.7%,P<.001)、一氧化碳弥散量受损(40%-75%:64% vs 51%;<40%:11% vs 4%,P<.001)及接受更多亚肺叶切除(34% vs 23%,P<.001)。
- ILD患者术后死亡率升高(5.1% vs 1.2%,P<.001)、急性呼吸窘迫综合征升高(1.9% vs 0.5%,P<.001)、复合并发症与死亡率升高(13.2% vs 7.4%,P<.001)。
- 校正患者合并症、肺功能、切除范围和中心容量效应后,ILD仍是死亡的强预测因素(OR 3.94,95%CI 3.09-5.01,P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior studies have noted that patients with interstitial lung disease (ILD) possess an increased incidence of lung cancer and risk of postoperative respiratory failure and death. We sought to understand the impact of ILD on national-scale outcomes of lung resection. METHODS: A retrospective cohort analysis using The Society of Thoracic Surgeons General Thoracic Surgery Database was conducted of patients who underwent a pulmonary resection for non-small cell lung cancer between 2009 and 2019. Baseline characteristics and postoperative outcomes were compared between patients with and without ILD (defined as interstitial fibrosis based on clinical, radiographic, or pathologic evidence). Multivariable logistic regression models identified risk factors associated with postoperative mortality, acute respiratory distress syndrome, and composite morbidity and mortality. RESULTS: ILD was documented in 1.5% (1873 of 128,723) of patients who underwent a pulmonary resection for non-small cell lung cancer. Patients with ILD were more likely to smoke (90% vs 85%, P < .001), have pulmonary hypertension (6% vs 1.7%, P < .001), impaired diffusing capacity of lung for carbon monoxide (diffusing capacity of lung for carbon monoxide 40%-75%: 64% vs 51%; diffusing capacity of lung for carbon monoxide <40%: 11% vs 4%, P < .001), and undergo more sublobar resections (34% vs 23%, P < .001) compared with patients without ILD. Patients with ILD had increased postoperative mortality (5.1% vs 1.2%, P < .001), acute respiratory distress syndrome (1.9% vs 0.5%, P < .001), and composite morbidity and mortality (13.2% vs 7.4%, P < .001). ILD remained a strong predictor of mortality (odds ratio, 3.94; 95% CI, 3.09-5.01; P < .001), even when adjusted for patient comorbidities, pulmonary function, extent of resection, and center volume effects. CONCLUSIONS: ILD is a risk factor for operative mortality and morbidity after lung cancer resection, even in patients with normal pulmonary function.
引用
- Axtell AL, David EA, Block MI, et al. Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection. Ann Thorac Surg. 2023. PMID: 37271447. doi:10.1016/j.athoracsur.2023.04.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。